Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ReST Therapeutics Logo
ReST Therapeutics CB Rank
230575
Heat Score
84
ReST Therapeutics is a clinical biotech that is using its successful seed funding.
Founded
obfuscation
PrivateGrant New Haven, Connecticut, United States1-10 www.rest-therapeutics.com
Biotechnology
Pharmaceutical
Overview

ReST Therapeutics
Heat Score
84

Growth Score
pts
in past quarter
Heat Score 84
17 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ReST Therapeutics

CB Rank
230575
ReST Therapeutics is a clinical biotech that is using its successful seed funding.
Founded
obfuscation
PrivateGrant New Haven, Connecticut, United States1-10 www.rest-therapeutics.com
Biotechnology
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
About the Company
ReST Therapeutics is a clinical biotech that is using its successful seed funding to push its patented medication candidate through non-clinical testing.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

RST-101
A drug candidate developed for early treatment of Post-Traumatic Stress Disorder (PTSD).
FENM (Fluoroethylnormemantine)
A novel NMDA receptor antagonist drug candidate for prevention and treatment of stress-induced maladaptive behavior and neuroprotection.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant

Funding Rounds

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
1
obfuscation
EIC AcceleratorGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
—
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
—
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
—
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
—
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - ReST Therapeutics Logo
Grant - ReST Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 2

Employee Profiles

News

News and Press

News•May 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

357
-46.07%
 in past month

IT Spend

$128.6KThis year, ReST Therapeutics is projected to spend $128.6K on IT, according to Aberdeen.

Active Website Tech Count

2ReST Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is ReST Therapeutics's headquarters? ReST Therapeutics is located in New Haven, Connecticut, United States.Who invested in ReST Therapeutics? ReST Therapeutics is funded by EIC Accelerator.When was the last funding round for ReST Therapeutics? ReST Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are ReST Therapeutics's competitors? Alternatives and possible competitors to ReST Therapeutics may include NRx Pharmaceuticals, Nexgel, and  Multidisciplinary Association for Psychedelic Studies.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b9b8747 1)
|